User login
David Henry's JCSO podcast, October 2014
In his monthly podcast for The Journal of Community and Supportive Oncology for October, David Henry examines two research articles that focus on patient-provider communication: one article looks at patient and provider concordance on symptoms and the other discusses the informational needs and the quality of life of patients after being diagnosed with metastatic breast cancer. Two other original research articles on weight change in breast cancer patients on third-generation adjuvant chemotherapy and the quality of supportive care in patients with advanced lung cancer in the Veterans Health Administration plus a Case Report about breast cancer with brain metastases in pregnancy round off the clinical portion of the line-up. A feature article details the current state of biomarker development and challenges that temper their clinical potential.
In his monthly podcast for The Journal of Community and Supportive Oncology for October, David Henry examines two research articles that focus on patient-provider communication: one article looks at patient and provider concordance on symptoms and the other discusses the informational needs and the quality of life of patients after being diagnosed with metastatic breast cancer. Two other original research articles on weight change in breast cancer patients on third-generation adjuvant chemotherapy and the quality of supportive care in patients with advanced lung cancer in the Veterans Health Administration plus a Case Report about breast cancer with brain metastases in pregnancy round off the clinical portion of the line-up. A feature article details the current state of biomarker development and challenges that temper their clinical potential.
In his monthly podcast for The Journal of Community and Supportive Oncology for October, David Henry examines two research articles that focus on patient-provider communication: one article looks at patient and provider concordance on symptoms and the other discusses the informational needs and the quality of life of patients after being diagnosed with metastatic breast cancer. Two other original research articles on weight change in breast cancer patients on third-generation adjuvant chemotherapy and the quality of supportive care in patients with advanced lung cancer in the Veterans Health Administration plus a Case Report about breast cancer with brain metastases in pregnancy round off the clinical portion of the line-up. A feature article details the current state of biomarker development and challenges that temper their clinical potential.
David Henry's JCSO podcast, September 2014
Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, is a report on bacteremia in adult cancer patients with apparently stable febrile neutropenia and another on practice gaps and barriers optimal care in patients with CML, ALL, or B-cell lymphomas. Also featured is a report on treatment patterns and clinical effectiveness in patients who are treated in the community setting for metastatic castrate-resistant prostate cancer after first-line docetaxel, as well as a Case Report on a patient with metastatic melanoma presenting as disseminated sporotrichosis.
Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, is a report on bacteremia in adult cancer patients with apparently stable febrile neutropenia and another on practice gaps and barriers optimal care in patients with CML, ALL, or B-cell lymphomas. Also featured is a report on treatment patterns and clinical effectiveness in patients who are treated in the community setting for metastatic castrate-resistant prostate cancer after first-line docetaxel, as well as a Case Report on a patient with metastatic melanoma presenting as disseminated sporotrichosis.
Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, is a report on bacteremia in adult cancer patients with apparently stable febrile neutropenia and another on practice gaps and barriers optimal care in patients with CML, ALL, or B-cell lymphomas. Also featured is a report on treatment patterns and clinical effectiveness in patients who are treated in the community setting for metastatic castrate-resistant prostate cancer after first-line docetaxel, as well as a Case Report on a patient with metastatic melanoma presenting as disseminated sporotrichosis.
Community Oncology Podcast - Carfilzomib and multiple myeloma
What’s the role of parenteral iron use in the oncology clinic? How does carfilzomib fit into the treatment of multiple myeloma? Listen to the the September podcast of Community Oncology from Editor-in-Chief Dr. David H. Henry.
What’s the role of parenteral iron use in the oncology clinic? How does carfilzomib fit into the treatment of multiple myeloma? Listen to the the September podcast of Community Oncology from Editor-in-Chief Dr. David H. Henry.
What’s the role of parenteral iron use in the oncology clinic? How does carfilzomib fit into the treatment of multiple myeloma? Listen to the the September podcast of Community Oncology from Editor-in-Chief Dr. David H. Henry.
Community Oncology Podcast - Abiraterone in metastatic prostate cancer
Editor-in-chief Dr. David H. Henry takes you on an audio tour of the August issue of Community Oncology featuring a Community Translation: Abiraterone boosts survival in metastatic prostate cancer and a review on maintenance therapy in solid tumors.
Editor-in-chief Dr. David H. Henry takes you on an audio tour of the August issue of Community Oncology featuring a Community Translation: Abiraterone boosts survival in metastatic prostate cancer and a review on maintenance therapy in solid tumors.
Editor-in-chief Dr. David H. Henry takes you on an audio tour of the August issue of Community Oncology featuring a Community Translation: Abiraterone boosts survival in metastatic prostate cancer and a review on maintenance therapy in solid tumors.
Community Oncology Podcast - Axitinib and sorafenib in advanced renal cell carcinoma.
Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.
Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.
Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.
Community Oncology Podcast - Aflibercept plus FOLFIRI for metastatic colorectal cancer
Join Editor-in-Chief Dr. David Henry for an audio discussion of the April issue, featuring aflibercept plus FOLFIRI for metastatic colorectal cancer, original research on depression and quality of life during chemotherapy, and the FDA's biosimilars guidelines.
Join Editor-in-Chief Dr. David Henry for an audio discussion of the April issue, featuring aflibercept plus FOLFIRI for metastatic colorectal cancer, original research on depression and quality of life during chemotherapy, and the FDA's biosimilars guidelines.
Join Editor-in-Chief Dr. David Henry for an audio discussion of the April issue, featuring aflibercept plus FOLFIRI for metastatic colorectal cancer, original research on depression and quality of life during chemotherapy, and the FDA's biosimilars guidelines.
Community Oncology Podcast - Targeted therapies in multiple myeloma
Join community Oncology's Editor-in-Chief Dr. David Henry for an audio tour of the March issue, featuring Dr. Kenneth C. Anderson's review of targeted therapies in multiple myeloma, Dr. Stuart M. Lichtman's commentary on treating cancer in elderly patients, and Dr. Jame Abraham's Community Translation article on vemurafenib for melanoma with the BRAF V600E mutation.
Join community Oncology's Editor-in-Chief Dr. David Henry for an audio tour of the March issue, featuring Dr. Kenneth C. Anderson's review of targeted therapies in multiple myeloma, Dr. Stuart M. Lichtman's commentary on treating cancer in elderly patients, and Dr. Jame Abraham's Community Translation article on vemurafenib for melanoma with the BRAF V600E mutation.
Join community Oncology's Editor-in-Chief Dr. David Henry for an audio tour of the March issue, featuring Dr. Kenneth C. Anderson's review of targeted therapies in multiple myeloma, Dr. Stuart M. Lichtman's commentary on treating cancer in elderly patients, and Dr. Jame Abraham's Community Translation article on vemurafenib for melanoma with the BRAF V600E mutation.